News
Alzheimer's Treatment Is Entering a New Era — Here Is Everything That Has Changed in 2026
Leqembi and Kisunla are slowing Alzheimer's decline by 27-35% in early-stage patients. The 2026 drug pipeline has 158 candidates in 192 trials. Prevention trials are beginning. Here's the full update.
→
Loneliness Raises Heart Valve Disease Risk by 19%, Major 2026 Study Finds — and It's Independent of Genetics
A 462,917-person, 14-year study published in JAHA found loneliness raises degenerative heart valve disease risk by up to 19%, independent of genetics and traditional risk factors.
→
Workplace Burnout Has Become a Public Health Emergency — Two-Thirds of American Workers Are Struggling, and the Health Costs Are Now Being Counted
A 2026 NAMI-Ipsos poll found 66% of U.S. workers report burnout. Healthcare workers: 76%. Gen Z: 74%. Chronic workplace stress contributes to an estimated 120,000 U.S. deaths per year. Here's what the evidence shows.
→
